The impact of diurnal variations, atopy, pollen exposure and pharmacotherapy on exhaled nitric oxide levels Source: Annual Congress 2011 - Bronchial hyperresponsiveness and exhaled and sputum biomarkers Year: 2011
High levels of fractional exhaled nitric oxide (FeNO) only reflect the degree of allergen sensitization in mild childhood asthma Source: Annual Congress 2005 - Monitoring paediatric asthma Year: 2005
Latex allergen exposure increases exhaled nitric oxide in symptomatic healthcare workers Source: Eur Respir J 2005; 25: 309-316 Year: 2005
Exhaled nitric oxide in specific challenge tests to assess occupational asthma Source: Eur Respir J 2002; 20: 1532-1537 Year: 2002
Changes of exhaled nitric oxide during steroid treatment of childhood asthma Source: Eur Respir J 2002; 19: 1015-1019 Year: 2002
Similar levels of nitric oxide in exhaled air in asthma and rhinitis after bronchial allergen challenge Source: Eur Respir J 2001; 18: Suppl. 33, 269s Year: 2001
Prevalence of asthma and exhaled nitric oxide are increased in bleachery workers exposed to ozone Source: Eur Respir J 2004; 23: 87-92 Year: 2004
Change in exhaled nitric oxide levels after removal from exposure in workers with occupational asthma Source: Annual Congress 2008 - Asthma and inhalation injuries at work Year: 2008
Exhaled nitric oxide, nitrite/nitrate levels, allergy, rhinitis and asthma in the EGEA study Source: Eur Respir J 2014; 44: 351-360 Year: 2014
Relationship between exhaled nitric oxide (eNO), atopy and asthma in children. ISAAC-clermont-ferrand Source: Eur Respir J 2001; 18: Suppl. 33, 38s Year: 2001
The effect of antioxidant therapy on nitric oxide metabolites in exhaled breath condensate in patients with pollen allergy and bronchial asthma Source: Annual Congress 2007 - Airway regulation, provocation and monitoring - III Year: 2007
High levels of fractional exhaled nitric oxide (FeNO) in severe oral steroid-dependent asthma are associated with eosinophilia and atopy Source: Annual Congress 2009 - Airway inflammation and asthma control Year: 2009
The effect of phosphogliv admission on exhaled nitric oxide level in patients with bronchial asthma Source: Annual Congress 2010 - Pharmacological modulation of biomarkers and management Year: 2010
The effect of phosphogliv admission on exhaled nitric oxide level in patients with bronchial asthma Source: Eur Respir J 2005; 26: Suppl. 49, 281s Year: 2005
Concordant reductions in total IgE and exhaled nitric oxide during oral steroid withdrawal in severe asthma at high altitude Source: Annual Congress 2009 - Severe asthma and its treatment Year: 2009
Exhaled nitric oxide and lower airway involvement in persistent rhinitis Source: Annual Congress 2006 - Monitoring airway inflammation – exhaled markers vs induced sputum Year: 2006
Exhaled nitric oxide in relation to asthma and atopy in adolescence Source: Annual Congress 2010 - Phenotypes, mechanisms and diagnosis of asthma in childhood Year: 2010
Effect of nitric oxide inhibition on immediate response to nasal allergen challenge in allergic rhinitis Source: Eur Respir J 2001; 18: Suppl. 33, 270s Year: 2001
Exhaled nitric oxide (eNO) levels in asthmatic children: relation to atopy and airway responsiveness (AHR) Source: Eur Respir J 2004; 24: Suppl. 48, 271s Year: 2004
Effect of montelukast treatment and withdrawal on exhaled nitric oxide and lung function in atopic asthmatic children Source: Annual Congress 2007 - Anti-inflammatory therapy for childhood asthma Year: 2007